PMID: 9193453May 1, 1997Paper

Enhanced hepatotoxicity of acetaminophen in the alcoholic patient. Two case reports and a review of the literature

Medicine
S C Johnston, L L Pelletier

Abstract

We report 2 fatal cases of the acetaminophen-alcohol syndrome and review 51 reported cases in the medical literature. The MEDLINE database from January 1966 to December 1995 and bibliographies of selected articles were used to obtain the case reports. Inclusion criteria were a clear history of alcohol use, a history of acetaminophen use and/or an elevated serum acetaminophen level, peak aspartate aminotransferase (AST) greater than 800 U/L, and exclusion of other causes of hepatotoxicity by negative hepatitis serologies and/or a liver biopsy showing typical findings of acetaminophen toxicity. Demographic characteristics, clinical features, treatment, and outcome were extracted from reports meeting inclusion criteria and our own 2 cases. This syndrome affected relatively young, frequently healthy patients. Acetaminophen was invariably taken for nonsuicidal intent. The mortality rate was 32%. A typical laboratory picture was defined, characterized by an extraordinarily high AST level. Treatment with N-acetylcysteine was not effective due to delayed presentation and diagnosis. Patients who use alcohol and health care providers should be educated about this potentially fatal syndrome. Prevention is the key to reducing its occurrence.

References

Aug 1, 1977·Annals of Internal Medicine·B Ameer, D J Greenblatt
Sep 1, 1977·Annals of Internal Medicine·J D BarkerS Anuras
May 1, 1992·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J Janes, P A Routledge
May 1, 1992·Journal of Internal Medicine·L S ErikssonM Lindholm
Sep 1, 1990·Southern Medical Journal·F T Wootton, W M Lee
Jun 1, 1989·Archives of Biochemistry and Biophysics·J L RaucyM Black
Feb 1, 1988·Journal of Clinical Gastroenterology·C J McClainS Shedlofsky
Jan 1, 1987·Acta Medica Scandinavica·C H FlorénA Nilsson
Mar 1, 1986·Annals of Internal Medicine·L B SeeffS B Benjamin
Aug 1, 1987·Scandinavian Journal of Gastroenterology·H DenisonS Wallerstedt
Jan 1, 1986·Digestive Diseases and Sciences·P B LesserW D Clark
Feb 1, 1985·Journal of Clinical Gastroenterology·M H LeistJ A Payne
Mar 1, 1967·Medicine·U HarinasutaH J Zimmerman
Oct 1, 1983·Hospital Practice·M Levinson
Feb 1, 1983·The American Journal of Medicine·A M DavisD R LaBrecque
Apr 1, 1982·Digestive Diseases and Sciences·M BlackN Shachter
Apr 1, 1980·Annals of Internal Medicine·H LichtH J Zimmerman
Apr 1, 1980·Annals of Internal Medicine·S S NairK Geraci
Feb 23, 1981·Archives of Internal Medicine·H J Zimmerman
Sep 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H J Zimmerman, W C Maddrey
Dec 21, 1994·JAMA : the Journal of the American Medical Association·D C Whitcomb, G D Block

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Treatment Options in Gastroenterology·S Chitturi, G C Farrell
Aug 26, 1998·The American Journal of Medicine·T J Schnitzer
Nov 12, 2002·The Journal of Emergency Medicine·Joshua E LaneAllison Scheetz
Sep 25, 1999·Clinics in Dermatology·M R Sanchez
Apr 12, 2000·British Journal of Clinical Pharmacology·L F Prescott
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·E TanakaS Misawa
Oct 27, 1997·The New England Journal of Medicine·F V SchiødtW M Lee
Nov 16, 2002·Orthopaedic Nursing·Marcia M DitmyerMatthew Pifer
Aug 23, 2011·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Chantale R BrunMichelle F Mottola
Sep 1, 2007·Medicine and Science in Sports and Exercise·Stuart M C LeeAlan R Hargens
Nov 17, 2009·Medicine and Science in Sports and Exercise·Suzanne M SchneiderAlan R Hargens
Nov 21, 2013·Annals of Surgery·John M FindlayNicholas D Maynard
Nov 27, 2004·Psychosomatic Medicine·G James RubinMatthew Hotopf
Mar 3, 2004·Emergency Medicine·Duncan Reid, Wayne Hazell
Jun 10, 2004·Arthritis and Rheumatism·Kenneth G SaagCatherine H MacLean
Oct 4, 2007·Journal of the American Geriatrics Society·Catherine H MacLeanKenneth G Saag
Jul 5, 2005·Expert Opinion on Investigational Drugs·J WuM A Zern
May 12, 1998·The American Journal of Gastroenterology·A Minocha, R Srinivasan
Nov 21, 2007·Journal of Clinical Laboratory Analysis·Amitava Dasgupta, Alice Wells
Oct 27, 2017·European Journal of Clinical Pharmacology·Thomas M CaparrottaJames W Dear
Feb 25, 2006·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Richard C DartUNKNOWN American Association of Poison Control Centers
Jul 10, 2021·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Ellen RootringJoseph D Tobias

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.